Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
Triple-negative breast cancer (TNBC) is one of the breast cancer subtype that displays a high risk of early recurrence and short overall survival. Improvement of the prognosis of patients with TNBC requires identifying a predictive factor of recurrence, which would make it possible to provide benefi...
Main Authors: | Yuko Hosokawa, Noritaka Masaki, Shiro Takei, Makoto Horikawa, Shoko Matsushita, Eiji Sugiyama, Hiroyuki Ogura, Norihiko Shiiya, Mitsutoshi Setou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5568295?pdf=render |
Similar Items
-
Correction: Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression.
by: Yoshimi Ide, et al.
Published: (2013-01-01) -
Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases
by: Ryuichiro Hirano, et al.
Published: (2023-02-01) -
Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
by: Inês Godet, et al.
Published: (2021-11-01) -
The Landscape of Targeted Therapies in TNBC
by: Elena Vagia, et al.
Published: (2020-04-01) -
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
by: Yuanzhen Ma, et al.
Published: (2024-04-01)